glp 1 europe Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say GLP-1 Analogues Market Report, Growth

Neurodegenerative Conditions Recent clinical research has demonstrated significant potential in treating various neurodegenerative conditions

J Neurotrauma 31:649657 Catroppa C, Godfrey C, Rosenfeld JV, Hearps SS, Anderson VA (2012) Functional recovery ten years after pediatric traumatic brain injury: outcomes and predictors

Symptom fluctuation in bulimia nervosa: Relation to menstrual-cycle phase and cortisol levels

Sperm quality is impaired by several abnormal conditions during spermatogenesis (1)

Glutathione is widely recognized for its antioxidant and antimelanogenesis properties, and this study investigated its potential as a depigmenting agent